Stocktoria
AdaptHealth Corp. AHCO
AdaptHealth Corp. (AHCO) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $3.2B at a -2.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.24 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.004 |
| Retained earnings / assets | -0.147 |
| EBIT / assets | 0.021 |
| Equity / liabilities | 0.547 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AHCO | AdaptHealth Corp. | 5/9 | 0.26 | — | -0.5% |
| CHE | CHEMED CORP | 5/9 | 9.65 | 23.2 | +4.1% |
| AVAH | Aveanna Healthcare Holdings, Inc. | 6/9 | -0.46 | 8.4 | +20.2% |
| ADUS | Addus HomeCare Corp | 7/9 | 5.5 | 18.9 | +23.2% |
| OPCH | Option Care Health, Inc. | 5/9 | 2.97 | 16.5 | +13% |
| EDGM | Edgemode, Inc. | 3/9 | — | — | — |
| BTSG | BrightSpring Health Services, Inc. | 7/9 | 1.78 | 71 | +28.2% |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
FAQ
Is AHCO financially healthy?
AdaptHealth Corp.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AHCO pay a dividend?
No, AdaptHealth Corp. does not currently pay a dividend.
How profitable is AHCO?
In FY2025, AdaptHealth Corp. had a net margin of -2.2% and a return on equity of -4.6%.
What is the analyst price target for AHCO?
The average Wall-Street price target for AdaptHealth Corp. is $14.00, about 142.6% above the recent price, from 8 analysts (consensus: buy).
Is AHCO a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on AdaptHealth Corp.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.